Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Ovarian Cancer 2015 NCI 1K22CA181550-01 Targeting defective DNA repair for the prevention of BRCA1-associated cancers ALLI, ELIZABETH WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $162,000
Ovarian Cancer 2015 NCI 3R01CA149429-05S1 The Mitochondrial Genome and Ovarian Cancer Risk PHELAN, CATHERINE H. LEE MOFFITT CANCER CTR & RES INST FL $25,000
Ovarian Cancer 2015 NCI 5K08CA151892-05 Targeting SRC Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer SIMPKINS, FIONA UNIVERSITY OF PENNSYLVANIA PA $30,798
Ovarian Cancer 2015 NIAID 5R01AI033993-21 Processed Antigen Characterization by Mass Spectrometry HUNT, DONALD UNIVERSITY OF VIRGINIA VA $633,862
Ovarian Cancer 2015 NCI 5R01CA158415-04 Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $356,850
Ovarian Cancer 2015 NCI 5R01CA079716-16 Ovarian Cancer: Epithelial Dedifferentiation XU, XIANGXI MIKE UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $326,412
Ovarian Cancer 2015 NCI 5R21CA182715-02 Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty FRIDLEY, BROOKE UNIVERSITY OF KANSAS MEDICAL CENTER KS $212,938
Ovarian Cancer 2015 NCI 5R01CA097061-12 Chemical genetic profiling of engineered tumor cells STOCKWELL, BRENT COLUMBIA UNIV NEW YORK MORNINGSIDE NY $350,176
Ovarian Cancer 2015 NCI 5R03CA181907-02 Diagnostic Utility of Culdocentesis in Patients with a Suspicious Adnexal Mass BRARD, LAURENT SOUTHERN ILLINOIS UNIVERSITY SCH OF MED IL $73,750
Ovarian Cancer 2015 NCI 5R01CA172743-03 Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients SUTPHEN, REBECCA UNIVERSITY OF SOUTH FLORIDA FL $216,572
Ovarian Cancer 2015 NCI 5R00CA168987-03 Discovering genomic rearrangements under selection in serious ovarian cancer SALZMAN, JULIA STANFORD UNIVERSITY CA $234,786
Ovarian Cancer 2015 NCI 5R03CA175462-02 Trial Participation Decision Making in Ovarian Cancer Patients and Their Families RADECKI BREITKOPF, CARMEN MAYO CLINIC ROCHESTER MN $79,500
Ovarian Cancer 2015 NCI 5R01CA174470-24 Stimulation of Tumorigenesis by NKG2D SPIES, THOMAS FRED HUTCHINSON CANCER RESEARCH CENTER WA $646,415
Ovarian Cancer 2015 NCI 5P30CA006516-50 6051 Gynecologic Cancers BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $93,399
Ovarian Cancer 2015 NCI 5P30CA006516-50 6064 Cancer Epidemiology HANKINSON, SUSAN BRIGHAM AND WOMEN'S HOSPITAL MA $82,467
Ovarian Cancer 2015 NCI 5R01CA135650-06 Predictive Cancer Diagnostics and Therapy Response MOORE, ANNA MASSACHUSETTS GENERAL HOSPITAL MA $552,368
Ovarian Cancer 2015 NCI 5R01CA163462-04 MUC1 Roles in ovarian cancer pathogenesis and immune therapy VLAD, ANDA MAGEE-WOMEN'S RES INST AND FOUNDATION PA $287,764
Ovarian Cancer 2015 NCI 5R01CA047135-25 Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $644,409
Ovarian Cancer 2015 NCI 5R01CA174643-08 The role of ERRalpha/PGC-1 in disease pathogenesis MCDONNELL, DONALD DUKE UNIVERSITY NC $314,209
Ovarian Cancer 2015 NCI 2P01CA087969-16 8092 Core A: Biospecimen and High-Dimensional Data Management Core TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $680,717
Ovarian Cancer 2015 NCI 2P01CA087969-16 8096 Project 3: Ovarian Cancer TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $240,125
Ovarian Cancer 2015 NCI 2P01CA087969-16 8097 Project 4: Statistical Innovations ROSNER, BERNARD BRIGHAM AND WOMEN'S HOSPITAL MA $150,307
Ovarian Cancer 2015 NIGMS 1SC1CA199810-01 Novel Nanotechnology Platform for Breast Cancer Treatment AKALA, EMMANUEL HOWARD UNIVERSITY DC $377,500
Ovarian Cancer 2015 NCI 1R01CA190423-01 Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $403,288
Ovarian Cancer 2015 NCI 1R01CA190498-01 gp130 as a novel therapeutic target in ovarian cancer NEAMATI, NOURI UNIVERSITY OF MICHIGAN MI $376,907
Ovarian Cancer 2015 NCI 1R01CA190237-01 Targeting BRCA Deficient Cells for Killing POMERANTZ, RICHARD TEMPLE UNIV OF THE COMMONWEALTH PA $356,850
Ovarian Cancer 2015 NIBIB 1R01EB019458-01 Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling CONOLLY, STEVEN UNIVERSITY OF CALIFORNIA BERKELEY CA $512,584
Ovarian Cancer 2015 NCI 1R01CA186700-01A1 Study of biomarkers in ovarian cancer: modulation by activity & diet intervention THOMSON, CYNTHIA UNIVERSITY OF ARIZONA AZ $647,789
Ovarian Cancer 2015 NCI 2P30CA015704-40 5446 Research Program: Women's Cancer PORTER, PEGGY FRED HUTCHINSON CANCER RESEARCH CENTER WA $71,271
Ovarian Cancer 2015 NCI 5UM1CA173642-03 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,539,856
Ovarian Cancer 2015 NCI 5R01CA182832-02 An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer MATEI, DANIELA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Ovarian Cancer 2015 NCI 1R21CA190930-01 Subharmonic Contrast Ultrasound for Improved Characterization of Adnexal Masses FORSBERG, FLEMMING THOMAS JEFFERSON UNIVERSITY PA $203,580
Ovarian Cancer 2015 NCI 5R01CA166711-03 Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport GANGJEE, ALEEM DUQUESNE UNIVERSITY PA $558,208
Ovarian Cancer 2015 NCI 1R21CA185808-01A1 Genetic Testing For Men From Hereditary Cancer Families SCHWARTZ, MARC GEORGETOWN UNIVERSITY DC $202,928
Ovarian Cancer 2015 NCI 1R21CA191690-01 Identifying BRCA1 protein variants that provide resistance to therapy JOHNSON, NEIL RESEARCH INST OF FOX CHASE CAN CTR PA $194,119
Ovarian Cancer 2015 NCI 1R03CA184394-01A1 Intraperitoneal Delivery of Targeted Nanoparticles for Metastatic Ovarian Cancer LU, XIULING UNIVERSITY OF CONNECTICUT STORRS CT $79,000
Ovarian Cancer 2015 NCI 5K99CA175292-02 Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms RIZVI, IMRAN BRIGHAM AND WOMEN'S HOSPITAL MA $174,871
Ovarian Cancer 2015 NCI 5R01CA163345-04 Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics BUCKANOVICH, RONALD UNIVERSITY OF MICHIGAN MI $322,663
Ovarian Cancer 2015 NCI 1R01CA175318-01A1 A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J. NJ $354,563
Ovarian Cancer 2015 NCI 5R01CA155025-05 The role of a novel BRCA1 associated complex in DNA damage response and tumor sup WANG, BIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2015 NIGMS 1R01GM113253-01A1 Role of the checkpoint clamp in double-strand break repair KAI, MIHOKO JOHNS HOPKINS UNIVERSITY MD $311,850
Ovarian Cancer 2015 NCI 5F31CA183531-02 Targeting Gain-of-Function p53 Missense Mutants SHAVER, TIMOTHY VANDERBILT UNIVERSITY TN $27,772
Ovarian Cancer 2015 NCI 5R01CA149669-06 CD73 and tumor immunity ZHANG, BIN NORTHWESTERN UNIVERSITY AT CHICAGO IL $311,894
Ovarian Cancer 2015 NCI 5R01CA169200-03 The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer BIRRER, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $372,052
Ovarian Cancer 2015 NCI 1R01CA184088-01A1 Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy KABANOV, ALEXANDER UNIV OF NORTH CAROLINA CHAPEL HILL NC $344,549
Ovarian Cancer 2015 NCI 5F32CA177094-02 Peptide-mediated delivery of siRNA for treatment of ovarian cancer KWON, ESTER MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $57,962
Ovarian Cancer 2015 NCI 1K22CA181611-01A1 Online monitoring and image-guided treatment of chemoresistant micrometastases SPRING, BRYAN NORTHEASTERN UNIVERSITY MA $186,276
Ovarian Cancer 2015 NCI 5R00CA139006-05 Development of Targeted Therapy for ERK Pathway in Breast Cancer BARTHOLOMEUSZ, CHANDRA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $249,000
Ovarian Cancer 2015 NCI 1R21CA187309-01A1 Ashwagandha supplementation enhances ovarian tumoricidal activity of NK cells BARUA, ANIMESH RUSH UNIVERSITY MEDICAL CENTER IL $214,128
Ovarian Cancer 2015 NCI 5R01CA159042-05 Personalizing Nanoparticle Therapy KUNDRA, VIKAS UNIVERSITY OF TX MD ANDERSON CAN CTR TX $324,113
Ovarian Cancer 2015 NCI 5R01CA148826-05 Characterizing Notch3 Signaling in Ovarian Cancer WANG, TIAN-LI JOHNS HOPKINS UNIVERSITY MD $340,300
Ovarian Cancer 2015 NCI 5R01CA152470-05 Memory T Cells in the Tumor Microenvironment ZOU, WEIPING UNIVERSITY OF MICHIGAN MI $393,042
Ovarian Cancer 2015 NCI 5R01CA169604-03 Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $392,850
Ovarian Cancer 2015 NCI 5K22CA175262-04 Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection SCHLACHER, KATHARINA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $200,340
Ovarian Cancer 2015 NCI 5R21CA178255-02 Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance. WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY MD $176,175
Ovarian Cancer 2015 NCI 5R01CA168758-03 Epidemiologic factors and survival by molecular subtypes of ovarian cancer ROSSING, MARY FRED HUTCHINSON CANCER RESEARCH CENTER WA $621,252
Ovarian Cancer 2015 NCI 5R01CA158119-04 Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens CRAMER, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $428,829
Ovarian Cancer 2015 NCI 5R01CA043054-28 Nuclear Function of Abl in DNA Damage Response WANG, JEAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Ovarian Cancer 2015 NCI 5F31CA183547-02 Epigenetics and Risk Factors for Breast and Ovarian Cancer in High Risk Women FERRIS, JENNIFER COLUMBIA UNIVERSITY HEALTH SCIENCES NY $41,643
Ovarian Cancer 2015 NCI 5R01CA160687-05 Targeted Development of Platinum Drugs SIDDIK, ZAHID UNIVERSITY OF TX MD ANDERSON CAN CTR TX $327,850
Ovarian Cancer 2015 NCI 5F30CA167895-04 Molecular analysis of the function of BRCA1-TONSL complexes HILL, SARAH HARVARD MEDICAL SCHOOL MA $45,762
Ovarian Cancer 2015 NCI 1R41CA192689-01 Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells SZOKA, FRANCIS ZONEONE PHARMA, INC. CA $298,920
Ovarian Cancer 2015 NCI 5R21CA185730-02 Blood-based Angiome Profiling to Direct Bevacizumab Therapy in Ovarian Cancer SECORD, ANGELES DUKE UNIVERSITY NC $207,061
Ovarian Cancer 2015 NCI 1R43CA186562-01A1 Modified MIS Production & Process Development for Preclinical & Clinical Studies COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $225,000
Ovarian Cancer 2015 NIGMS 5F32GM110978-02 Deciphering the epistatic relationships of RAD51 Paralogs in mammary epithelium PRAKASH, ROHIT SLOAN-KETTERING INST CAN RESEARCH NY $59,966
Ovarian Cancer 2015 NCI 5R01CA172272-03 The BARD1 tumor suppressor and breast cancer BAER, RICHARD COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Ovarian Cancer 2015 NCI 5R01CA157664-05 Initiation and evolution of the ovarian cancer microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $379,960
Ovarian Cancer 2015 NCI 5R01CA158881-05 Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer COLEMAN, TIMOTHY NEMUCORE MEDICAL INNOVATIONS, INC. MA $523,530
Ovarian Cancer 2015 NCI 5R01CA181543-02 Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells BRUGGE, JOAN HARVARD MEDICAL SCHOOL MA $397,851
Ovarian Cancer 2015 NCI 5R01CA183040-02 Ovarian cancer gene therapy using HPV pseudovirion WU, TZYY-CHOOU JOHNS HOPKINS UNIVERSITY MD $336,150
Ovarian Cancer 2015 NCI 5R01CA160669-04 Mitochondrial DNA and Ovarian Cancer Risk and Survival COOK, LINDA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $505,309
Ovarian Cancer 2015 NCI 5R01CA154460-05 CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res SANTIN, ALESSANDRO YALE UNIVERSITY CT $345,488
Ovarian Cancer 2015 NCI 5R01CA174904-03 Roles of Chromatin Modification in BRCA1 Dependent DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $332,000
Ovarian Cancer 2015 NIBIB 5R01EB016582-03 Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer NOLTE, DAVID PURDUE UNIVERSITY IN $317,506
Ovarian Cancer 2015 NCI 5U10CA180860-02 Integrated Translational Genoproteomics Center at Washington University MUTCH, DAVID WASHINGTON UNIVERSITY MO $570,826
Ovarian Cancer 2015 NCI 5R01CA184968-02 (PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers SIKIC, BRANIMIR STANFORD UNIVERSITY CA $509,161
Ovarian Cancer 2015 NCI 5R01CA109545-09 Receptor Cross-Talk in Early Metastatic Dissemination STACK, MARY UNIVERSITY OF NOTRE DAME IN $298,049
Ovarian Cancer 2015 NCI 5R01CA155305-05 Multiplexed Detection of Cell Free DNA Biomarkers for Cancer WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY MD $340,300
Ovarian Cancer 2015 NCI 5U01CA176058-03 The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center HAHN, WILLIAM DANA-FARBER CANCER INST MA $703,315
Ovarian Cancer 2015 NIGMS 5R01GM111093-02 Glycosylation-dependent mechanisms regulating ovarian tumor cell survival BELLIS, SUSAN UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $279,300
Ovarian Cancer 2015 NCI 5R01CA184502-02 (PQD5) Avatar-directed Treatment for Ovarian Cancer WEROHA, SARAVUT MAYO CLINIC ROCHESTER MN $642,667
Ovarian Cancer 2015 NCI 5R01CA151570-05 Co-registered photoacoustic and ultrasound imaging for non-invasive ovarian can ZHU, QUING UNIVERSITY OF CONNECTICUT STORRS CT $324,140
Ovarian Cancer 2015 NCI 5R01CA109298-11 Ovarian Cancer: Mechanisms of Neuroendocrine Regulation SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $359,706
Ovarian Cancer 2015 NCI 5R01CA131407-08 Re-activating Memory T Cells in the Microenvironment of Human Tumors BANKERT, RICHARD STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $326,334
Ovarian Cancer 2015 NCI 5K99CA184043-02 Targeting Ovarian Cancer via Cooperative Oncogene Interactions HARGREAVES, DIANA STANFORD UNIVERSITY CA $171,072
Ovarian Cancer 2015 NCI 5R01CA160998-05 Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry HASAN, TAYYABA MASSACHUSETTS GENERAL HOSPITAL MA $387,435
Ovarian Cancer 2015 NIBIB 5R01EB007268-08 Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity YANG, JENNY GEORGIA STATE UNIVERSITY GA $459,558
Ovarian Cancer 2015 NICHD 5R01HD073499-03 Genetic regulation of ovariole development in Drosophila EXTAVOUR, CASSANDRA HARVARD UNIVERSITY MA $309,413
Ovarian Cancer 2015 NCI 5R01CA175480-03 Tumor-targeted Polymersomes to image and Treat Ovarian Cancer CHENG, ZHILIANG UNIVERSITY OF PENNSYLVANIA PA $327,765
Ovarian Cancer 2015 NCI 5R01CA068682-24 Biomedical Applications of Expanded Porphyrins SESSLER, JONATHAN UNIVERSITY OF TEXAS, AUSTIN TX $320,588
Ovarian Cancer 2015 NCI 5R01CA177909-03 Platelets promote growth of ovarian cancer AFSHAR-KHARGHAN, VAHID UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Ovarian Cancer 2015 NCI 5R01CA163377-04 Role of EZH2 in Epithelial Ovarian Cancer ZHANG, RUGANG WISTAR INSTITUTE PA $345,488
Ovarian Cancer 2015 NCI 5R01CA180769-07 Signaling Connections Controlling Cell Motility and Invasion SCHLAEPFER, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $376,450
Ovarian Cancer 2015 NIGMS 1R01GM113940-01 NIR-activatable Prodrugs for Treating Peritoneally Metastasized Ovarian Cancers YOU, YOUNGJAE UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $279,404
Ovarian Cancer 2015 NCI 5R01CA176078-02 Dissecting the role of STAT3 and targeting ovarian cancer KARUPPAIYAH, SELVENDIRAN OHIO STATE UNIVERSITY OH $323,379
Ovarian Cancer 2015 NCI 5R01CA075334-18 MRI studies of angiogenesis in ovarian cancer NEEMAN, MICHAL WEIZMANN INSTITUTE OF SCIENCE ISRAEL $102,773
Ovarian Cancer 2015 NCI 1U01CA194393-01 Quantifying and Characterizing the shared genetic contribution to common cancers LINDSTROEM, SARA HARVARD SCHOOL OF PUBLIC HEALTH MA $675,732
Ovarian Cancer 2015 NCI 5U01CA176270-03 Profiling cancer neoantigen repertoires and validating immunotherapy targets MCINTOSH, MARTIN FRED HUTCHINSON CANCER RESEARCH CENTER WA $1,069,555
Ovarian Cancer 2015 NCI 5R01CA157481-04 Bmi-1, a potential therapeutic target in ovarian cancer BHATTACHARYA, RESHAM UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $311,480
Ovarian Cancer 2015 NCI 5F31CA177325-02 Inflammatory Basis of Depression in Ovarian Cancer SCHREPF, ANDREW UNIVERSITY OF IOWA IA $8,598
Ovarian Cancer 2015 NCI 1K99CA194318-01 Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer BITLER, BENJAMIN WISTAR INSTITUTE PA $115,014
Ovarian Cancer 2015 NCI 1K99CA194309-01 Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer AIRD, KATHERINE WISTAR INSTITUTE PA $115,014
Ovarian Cancer 2015 NLM 1K01LM012100-01 Informatic Methods for Differential Signaling and Immune Co-Regulatory Expression ENG, KEVIN ROSWELL PARK CANCER INSTITUTE CORP NY $168,195
Ovarian Cancer 2015 NCI 5R01CA164122-04 B7-H1 Signaling in Ovarian Cancer CURIEL, TYLER UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $310,213
Ovarian Cancer 2015 NCI 5R01CA111882-09 Regulation of Adhesion and Proteolysis in Ovarian Cancer LENGYEL, ERNST UNIVERSITY OF CHICAGO IL $272,318
Ovarian Cancer 2015 NCI 5U01CA168409-04 COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS POWERS, SCOTT COLD SPRING HARBOR LABORATORY NY $1,420,487
Ovarian Cancer 2015 NCI 5U01CA181628-02 Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery PTASZEK, MARCIN UNIVERSITY OF MARYLAND BALT CO CAMPUS MD $196,403
Ovarian Cancer 2015 NCI 5R01CA172404-03 Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer RAMUS, SUSAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $687,307
Ovarian Cancer 2015 NCI 1R21CA194626-01 (PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women ORSULIC, SANDRA CEDARS-SINAI MEDICAL CENTER CA $227,288
Ovarian Cancer 2015 NCI 5R01CA176166-02 Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer CANTOR, SHARON UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Ovarian Cancer 2015 NCI 5R21CA182748-02 Targeting TF/CD44v6 for In Vivo Nano-generated alpha-therapy of Ovarian Cancer DEUTSCHER, SUSAN UNIVERSITY OF MISSOURI-COLUMBIA MO $198,177
Ovarian Cancer 2015 NICHD 1R15HD075257-01A1 Regulation of Primordial Follicle Formation and Oocyte Survival PEPLING, MELISSA SYRACUSE UNIVERSITY NY $440,204
Ovarian Cancer 2015 NCI 5U01CA116167-08 BRCA1 and BRCA2 missense mutations and breast cancer risk COUCH, FERGUS MAYO CLINIC ROCHESTER MN $527,128
Ovarian Cancer 2015 NCI 5R21CA178468-02 Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy NANJUNDAN, MEERA UNIVERSITY OF SOUTH FLORIDA FL $161,301
Ovarian Cancer 2015 NCI 1R03CA184306-01A1 Development of a Web-Based Group Intervention to Support Ovarian Cancer Survivors LUTGENDORF, SUSAN UNIVERSITY OF IOWA IA $92,196
Ovarian Cancer 2015 NCI 5F32CA183214-02 The use of epigenetic therapy to activate an immune response in ovarian cancer CHIAPPINELLI, KATHERINE JOHNS HOPKINS UNIVERSITY MD $54,194
Ovarian Cancer 2015 NCI 5R01CA124515-10 Vascular Leukocytes Influence the Tumor Microenvironment CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $340,955
Ovarian Cancer 2015 NCCAM 5R01AT005295-05 Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer HALES, DALE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE IL $349,309
Ovarian Cancer 2015 NCI 5R01CA166907-03 Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity RAMKUMAR, VICKRAM SOUTHERN ILLINOIS UNIVERSITY SCH OF MED IL $301,918
Ovarian Cancer 2015 NCI 5U01CA168870-04 Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer ABBOTT, KAREN UNIV OF ARKANSAS FOR MED SCIS AR $441,461
Ovarian Cancer 2015 NCI 5R03CA189462-02 Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer DINULESCU, DANIELA BRIGHAM AND WOMEN'S HOSPITAL MA $85,285
Ovarian Cancer 2015 NCI 5R01CA181258-02 Chemically Programmed Bispecific Antibodies for Cancer Therapy RADER, CHRISTOPH SCRIPPS FLORIDA FL $398,400
Ovarian Cancer 2015 NCI 2R01CA142698-06 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $408,989
Ovarian Cancer 2015 NCI 2R01CA115483-11 Therapeutic Targeting Agents for Ovarian Cancer LAM, KIT UNIVERSITY OF CALIFORNIA AT DAVIS CA $305,863
Ovarian Cancer 2015 NCI 5P01CA066726-18 5805 Clinical Trials in Mesothelioma STERMAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $302,808
Ovarian Cancer 2015 NCI 5R01CA158318-05 mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $347,118
Ovarian Cancer 2015 NCI 5R21CA187765-02 Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer? COOPER, PRISCILLA UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB CA $214,718
Ovarian Cancer 2015 NCI 1R01CA190176-01A1 Effector T Cell Trafficking in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN MI $514,525
Ovarian Cancer 2015 NCI 5R21CA187278-02 Diagnostic Assays for OVCA Recurrence using Paraneoplastic Antigens and Epitopes TAINSKY, MICHAEL WAYNE STATE UNIVERSITY MI $198,360
Ovarian Cancer 2015 NCI 2R01CA138835-06A1 The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $332,509
Ovarian Cancer 2015 NCI 5R21CA187512-02 TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA WANG, TIAN-LI JOHNS HOPKINS UNIVERSITY MD $176,175
Ovarian Cancer 2015 NCI 5R01CA121113-09 Large-scale Genetic Analyses of Human Cancer VELCULESCU, VICTOR JOHNS HOPKINS UNIVERSITY MD $279,212
Ovarian Cancer 2015 NCI 5K23CA159391-04 Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus PEIKERT, TOBIAS MAYO CLINIC ROCHESTER MN $164,160
Ovarian Cancer 2015 NCI 1R01CA178048-01A1 Fas protects cancer stem cells from death PETER, MARCUS NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,419
Ovarian Cancer 2015 NCI 5K07CA166210-03 Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer WRIGHT, ALEXI DANA-FARBER CANCER INST MA $177,120
Ovarian Cancer 2015 NCI 5R01CA178687-03 Effects of common polymorphisms in immune sensors in tumor immunosurveillance CONEJO-GARCIA, JOSE WISTAR INSTITUTE PA $377,972
Ovarian Cancer 2015 NCI 1R01CA195670-01 The Tumor Suppressor Role of SMARCA4 in SCCOHT WEISSMAN, BERNARD UNIV OF NORTH CAROLINA CHAPEL HILL NC $697,118
Ovarian Cancer 2015 NCI 1R01CA182413-01A1 Origins of Ovarian Carcinoma NIKITIN, ALEXANDER CORNELL UNIVERSITY NY $358,780
Ovarian Cancer 2015 NCI 1R01CA188900-01A1 Novel immunological biomarkers ovarian cancer prognosis SEGAL, BRAHM ROSWELL PARK CANCER INSTITUTE CORP NY $589,735
Ovarian Cancer 2015 NCI 5P30CA046592-27 6455 Cancer Genetics WICHA, MAX UNIVERSITY OF MICHIGAN MI $310,178
Ovarian Cancer 2015 NCI 5R21CA186846-02 Integrated Microfluidic Exosome Profiling for Early Detection of Cancer ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE KS $212,274
Ovarian Cancer 2015 NIAID 5K06AI004739-54 BIOCHEMISTRY OF VIRAL REPLICATION GREEN, MAURICE SAINT LOUIS UNIVERSITY MO $33,939
Ovarian Cancer 2015 NCI 5R01CA180710-03 Targeting nucleotide excision repair in combination cancer therapy TURCHI, JOHN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Ovarian Cancer 2015 NCI 5R01CA178535-03 The contribution of rare alleles to ovarian cancer in the population GAYTHER, SIMON UNIVERSITY OF SOUTHERN CALIFORNIA CA $609,595
Ovarian Cancer 2015 NCI 7R01CA187209-02 Functional analysis of BRCA1 in DNA damage response and tumor suppression YU, XIAOCHUN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $352,750
Ovarian Cancer 2015 NCI 5F31CA183463-02 Regulation of REDD1 and caspase-2 by FASN inhibition in ovarian cancer LINDBLOM, KELLY DUKE UNIVERSITY NC $33,326
Ovarian Cancer 2015 NCI 5F30CA189316-02 The Role of NFAT3 in Quiescence and Chemoresistance in Ovarian Cancer Stem Cells IYENGAR, MANGALA UNIVERSITY OF MICHIGAN MI $33,625
Ovarian Cancer 2015 NCI 1R01CA195723-01 Validating a mouse model of ovarian cancer for early detection through imaging BARTON, JENNIFER UNIVERSITY OF ARIZONA AZ $572,656
Ovarian Cancer 2015 NCI 5R41CA180773-02 Ovarian cancer using novel nanoparticle formulations CHIRIVA-INTERNATI, MAURIZIO KIROMIC, LLC TX $101,844
Ovarian Cancer 2015 NCI 5U24CA160036-05 Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers CHAN, DANIEL JOHNS HOPKINS UNIVERSITY MD $1,859,557
Ovarian Cancer 2015 NCI 1F32CA196008-01 Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer CHEN, HSING-YU HARVARD MEDICAL SCHOOL MA $54,194
Ovarian Cancer 2015 NCI 1F31CA186376-01A1 Role of estrogen receptor-alpha in ovarian cancer ANDERSEN, COURTNEY UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $43,120
Ovarian Cancer 2015 NCI 5R01CA131582-06 Identification of Ovarian Cancer Plasma Biomarkers SPEICHER, DAVID WISTAR INSTITUTE PA $440,659
Ovarian Cancer 2015 NCI 2R01CA095175-11A1 Analysis of BRCA1 Recombination Functions SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER MA $330,600
Ovarian Cancer 2015 NCI 5F31CA174316-04 Structural mutation analysis of PTEN and its possible genotype-phenotype correlat SMITH, IRIS UNIVERSITY OF HOUSTON TX $28,622
Ovarian Cancer 2015 NCI 5R01CA164729-04 Integrative Cancer Genomics: Drivers, Pathways and Drugs PE'ER, DANA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $554,295
Ovarian Cancer 2015 NCI 5K01CA172591-04 EGF receptor, DNA methylation and platinum resistance in ovarian cancer SAMUDIO-RUIZ, SABRINA UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $129,216
Ovarian Cancer 2015 NCI 5U54CA096300-13 6961 In Vivo Assessment of Localized Magnetic Fluid Hyperthermia for Ovarian Cancer SOOD, ANIL UNIVERSITY OF PUERTO RICO PR $89,694
Ovarian Cancer 2015 NCI 5R01CA184717-02 The Regulation of Cisplatin resistance in ovarian cancer ZHU, WENGE GEORGE WASHINGTON UNIVERSITY DC $328,888
Ovarian Cancer 2015 NCI 5U54CA163071-04 7991 Identifying Cancer Health Communication Channels for Hispanic Audiences JIMENEZ, JUILO PONCE SCHOOL OF MEDICINE PR $91,909
Ovarian Cancer 2015 NCI 5R21CA181923-02 Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer PIKE, MALCOLM SLOAN-KETTERING INST CAN RESEARCH NY $191,291
Ovarian Cancer 2015 NCI 5F30CA183395-02 Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy COCCE, KIMBERLY DUKE UNIVERSITY NC $33,531
Ovarian Cancer 2015 NCI 5P50CA159981-03 5590 Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $476,157
Ovarian Cancer 2015 NCI 5P50CA159981-03 5591 Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov SHRIKANT, PROTUL ROSWELL PARK CANCER INSTITUTE CORP NY $617,258
Ovarian Cancer 2015 NCI 5P50CA159981-03 5593 MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1 KALINSKI, PAWEL UNIVERSITY OF PITTSBURGH PA $628,850
Ovarian Cancer 2015 NCI 5P50CA159981-03 5594 Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $94,889
Ovarian Cancer 2015 NCI 5P50CA159981-03 5595 Administrative Core ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $53,116
Ovarian Cancer 2015 NCI 5P50CA159981-03 5596 Biospecimen Core MORRISON, CARL ROSWELL PARK CANCER INSTITUTE CORP NY $52,762
Ovarian Cancer 2015 NCI 5P50CA159981-03 5597 Biostatistics/Medical Informatics HUTSON, ALAN ROSWELL PARK CANCER INSTITUTE CORP NY $40,604
Ovarian Cancer 2015 NCI 5P50CA159981-03 5598 Immune Monitoring Core WALLACE, PAUL ROSWELL PARK CANCER INSTITUTE CORP NY $72,022
Ovarian Cancer 2015 NCI 5P50CA159981-03 5599 Developmental Research Program MOYSICH, KIRSTEN ROSWELL PARK CANCER INSTITUTE CORP NY $48,893
Ovarian Cancer 2015 NCI 5P50CA159981-03 5600 Career Development Program LELE, SHASHIKANT ROSWELL PARK CANCER INSTITUTE CORP NY $43,449
Ovarian Cancer 2015 NCI 5R01CA163451-04 Psychological stress, associate biologic mediators, and ovarian cancer risk TWOROGER, SHELLEY BRIGHAM AND WOMEN'S HOSPITAL MA $412,105
Ovarian Cancer 2015 NCI 5R21CA175975-02 Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer PEIPER, STEPHEN THOMAS JEFFERSON UNIVERSITY PA $169,650
Ovarian Cancer 2015 NCI 5P01CA154292-05 5435 Risk Assessment in Community Practice: Developing Better Models KERLIKOWSKE, KARLA GROUP HEALTH COOPERATIVE WA $477,743
Ovarian Cancer 2015 NCI 5R42CA156933-03 Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer KOPECEK, JINDRICH THERATARGET UT $492,378
Ovarian Cancer 2015 NCI 5F30CA171715-04 Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer LOU, DIANNE UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $37,308
Ovarian Cancer 2015 NCI 5R01CA181808-02 Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis RICHARDS, JOANNE BAYLOR COLLEGE OF MEDICINE TX $336,565
Ovarian Cancer 2015 NCI 5R03CA182120-02 Inflammation, autoimmunity and ovarian cancer LUBORSKY, JUDITH WOODS HOLE OCEANOGRAPHIC INSTITUTION MA $69,119
Ovarian Cancer 2015 NCI 5UM1CA182910-02 Shanghai Womens Health Study ZHENG, WEI VANDERBILT UNIVERSITY TN $1,315,484
Ovarian Cancer 2015 NCI 5U01CA184910-02 Validation of findings from the Epigenome-Wide Association Study of Breast Cancer STURGEON, SUSAN UNIVERSITY OF MASSACHUSETTS AMHERST MA $1
Ovarian Cancer 2015 NCI 5R01CA188025-02 Iron addiction and the biology of ovarian cancer TORTI, SUZY UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $379,016
Ovarian Cancer 2015 NCI 2P30CA047904-27 6388 Cancer Epidemiology and Prevention Program (Project-005) YUAN, JIAN-MIN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $36,087
Ovarian Cancer 2015 NCI 2P30CA047904-27 6390 Breast and Ovarian Cancer Program (Project-007) LEE, ADRIAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $34,779
Ovarian Cancer 2015 OD 5R03CA178763-02 Young Women From BRCA1/2 Families: A Family History And A Future O'NEILL, SUZANNE GEORGETOWN UNIVERSITY DC $77,750
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7019 Biospecimens and Patient Registry KEENEY, GARY MAYO CLINIC ROCHESTER MN $132,843
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7020 Core C - Biostatistics Core OBERG, ANN MAYO CLINIC ROCHESTER MN $146,934
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7021 Core D - Animal Models Core HALUSKA, PAUL MAYO CLINIC ROCHESTER MN $127,738
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7022 Administrative Core KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $587,017
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7023 Project 1 - PARP Project KAUFMANN, SCOTT MAYO CLINIC ROCHESTER MN $173,132
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7024 Project 6 - PKC Iota FIELDS, ALAN MAYO CLINIC ROCHESTER MN $271,794
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7025 Project 7 - Metformin LENGYEL, ERNST MAYO CLINIC ROCHESTER MN $337,376
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7026 Project 8 - TH17 Dendritic Cell Vaccine KNUTSON, KEITH MAYO CLINIC ROCHESTER MN $265,812
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7027 Developmental Reserach Pilot Projects CLIBY, WILLIAM MAYO CLINIC ROCHESTER MN $94,902
Ovarian Cancer 2015 NCI 2P50CA136393-06A1 7028 Career Development GOODE, ELLEN MAYO CLINIC ROCHESTER MN $47,451
Ovarian Cancer 2015 NCI 5P30CA010815-46 6194 Tumor Microenvironment and Metastasis ALTIERI, DARIO WISTAR INSTITUTE PA $31,164
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7470 Adminstrative Core SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $82,874
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7471 Biostatistics Core IASONOS, ALEXIA SLOAN-KETTERING INST CAN RESEARCH NY $79,911
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7472 Pathology Core DELAIR, DEBORAH SLOAN-KETTERING INST CAN RESEARCH NY $82,873
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7473 MUC16 Antibody Based Strategies for Imaging and Therapy SPRIGGS, DAVID SLOAN-KETTERING INST CAN RESEARCH NY $580,100
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7474 Personalized Immunotherapy of Patients with Ovarian Cancer SABBATINI, PAUL SLOAN-KETTERING INST CAN RESEARCH NY $497,223
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7475 Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells BRENTJENS, RENIER SLOAN-KETTERING INST CAN RESEARCH NY $414,354
Ovarian Cancer 2015 NCI 1P01CA190174-01A1 7476 Enhanced Efficacy of MUC16 directed antibodies through modification of the Fc domain RAVETCH, JEFFREY SLOAN-KETTERING INST CAN RESEARCH NY $315,472
Ovarian Cancer 2015 NCI 5F31CA192891-02 Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer PRICE, JESSICA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $43,887
Ovarian Cancer 2015 NCI 5U54CA118948-10 8553 Development Core MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $527,326
Ovarian Cancer 2015 NCI 1R01CA197359-01 Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy BERLIN, JACOB CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $388,875
Ovarian Cancer 2015 NCI 1R21CA197225-01 Generation and characterization of adduct-specific anti cisplatin DNA antibodies SCHARER, ORLANDO STATE UNIVERSITY NEW YORK STONY BROOK NY $204,071
Ovarian Cancer 2015 NCI 1R01CA199004-01 Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer MOR, GIL YALE UNIVERSITY CT $511,177
Ovarian Cancer 2015 NCI 1R35CA197458-01 GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER KING, MARY-CLAIRE UNIVERSITY OF WASHINGTON WA $927,000
Ovarian Cancer 2015 NCI 1R21CA187289-01A1 Mitochondrially Targeted p53 DBD for Treatment of Ovarian Cancer LIM, CAROL UNIVERSITY OF UTAH UT $162,038
Ovarian Cancer 2015 NCI 1R15CA188847-01A1 Nano-cocktail overcomes multidrug-resistance for ovarian cancer therapy XU, PEISHENG UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $366,250
Ovarian Cancer 2015 NCI 1R03CA191447-01A1 Validation and Clinical Relevance of Ovarian Cancer Molecular Subtypes WALDRON, LEVI HUNTER COLLEGE NY $77,583
Ovarian Cancer 2015 NCI 1R21CA198409-01 Targeting Ovarian Cancer Stem Cells Through Selective Inhibition of ALDH1A1 HURLEY, THOMAS INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $203,397
Ovarian Cancer 2015 NCI 1R21CA198795-01 PET Kinetic Modeling of Inhibiting Glycolysis in Ovarian Cancer AVRIL, NORBERT CASE WESTERN RESERVE UNIVERSITY OH $185,247
Ovarian Cancer 2015 NCI 1R21CA191725-01A1 4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci FREEDMAN, MATTHEW DANA-FARBER CANCER INST MA $223,181
Ovarian Cancer 2015 NCI 1R03CA198822-01 Scutellaria Baicalensis Targets HIF-1(alpha) in Cancer SYED, VIQAR HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $77,878
Ovarian Cancer 2015 NCI 1R43CA192674-01A1 NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION LELENTAL, MARK CATASSAYS NY $225,000
Ovarian Cancer 2015 NCI 1R01CA193136-01A1 MDSCs in Ovarian Cancer ZOU, WEIPING UNIVERSITY OF MICHIGAN MI $498,257
Ovarian Cancer 2015 RMAP 4UH3TR000943-03 Novel extra cellular RNA-based combinatorial RNA inhibition therapy SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $999,500
Ovarian Cancer 2015 NCI 2R01CA142746-06A1 Enzyme-instructed self-assembly for molecular anticancer nanomedicines XU, BING BRANDEIS UNIVERSITY MA $383,751
Ovarian Cancer 2015 NCI 1R01CA188571-01A1 DYRK1A signaling in control of cell growth, proliferation and DNA damage repair LITOVCHICK, LARISA VIRGINIA COMMONWEALTH UNIVERSITY VA $348,844
Ovarian Cancer 2015 NCI 1R01CA188943-01A1 Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors HILDEBRANDT, MICHELLE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $1,234,720
Ovarian Cancer 2015 NCI 2R01CA135354-05 ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $380,000
Ovarian Cancer 2015 NCI 5F31CA186625-02 Refining ovarian cancer subtype classifiers to incorporate biologic features RUDD, JAMES DARTMOUTH COLLEGE NH $43,120
Ovarian Cancer 2015 NCI 3P50CA159981-03S1 RPCI-UPCI Ovarian Cancer SPORE ODUNSI, KUNLE ROSWELL PARK CANCER INSTITUTE CORP NY $66,758
Ovarian Cancer 2015 NCI 3UM1CA173642-03S1 Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI Clinical Trial and Observational Cohorts ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $113,842
Ovarian Cancer 2015 NINR 1F31NR015170-01A1 Hormone Therapy Decision Making in Older Women HUNTER, MARY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $34,571
Ovarian Cancer 2015 NCI 1F30CA192648-01A1 Deciphering Links Between Inflammation and Cancer with IMP-1 Inhibitors MAHAPATRA, LILY UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $48,120
Ovarian Cancer 2015 NCI 1R01CA193578-01A1 Tunable Microchip Sorting of BRCA1 Nuclear Assemblies KELLY, DEBORAH VIRGINIA POLYTECHNIC INST AND ST UNIV VA $353,386
Ovarian Cancer 2015 NCI 2R01CA102310-12A1 Role of FAK in Tumorigenesis SCHLAEPFER, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $331,313
Ovarian Cancer 2015 NCI 1R01CA196200-01A1 Ovarian Cancer Chemoprevention BENBROOK, DORIS UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $611,847
Ovarian Cancer 2015 NCI 3R01CA047135-25S1 Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $38,168
Ovarian Cancer 2015 NCI 1SC2CA206194-01A1 Theranostic nanoparticles for dual modality cancer therapy CZAJKOWSKA, ANETA BROOKLYN COLLEGE NY $157,000
Ovarian Cancer 2015 NIBIB 1R43EB021212-01 CTC Screening Assay to Address Health Disparities in Women with Ovarian Cancer HUPERT, MATEUSZ BIOFLUIDICA, INC NC $199,848
Ovarian Cancer 2015 NIGMS 1R01GM116829-01 Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaks MER, GEORGES MAYO CLINIC ROCHESTER MN $314,025
Ovarian Cancer 2015 NCI 261200800001E-77-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $2,282,355
Ovarian Cancer 2015 NCI 261201100008C-13-0-1 CENTRAL DATA COLLECTION CENTER (CDCC) CONTINUED FOLLOW-UP OF PLCO MATHEW, SUNITHA WESTAT, INC. MD $1,716,430
Ovarian Cancer 2015 NCI 3R01CA047135-25S2 Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics CREWS, PHIL UNIVERSITY OF CALIFORNIA SANTA CRUZ CA $63,494
Ovarian Cancer 2015 NCI 3R01CA142783-05S2 Signaling in the ovarian cancer metastatic microenvironment SLACK-DAVIS, JILL UNIVERSITY OF VIRGINIA VA $60,458
Ovarian Cancer 2015 RMAP 3UH3TR000943-03S1 Novel extra cellular RNA-based combinatorial RNA inhibition therapy SOOD, ANIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $79,168
Ovarian Cancer 2015 NICHD 3R01HD073499-03S1 Genetic regulation of ovariole development in Drosophila EXTAVOUR, CASSANDRA HARVARD UNIVERSITY MA $100,001
Ovarian Cancer 2015 NCI 7R01CA142081-06 Epidemiology of Ovarian Cancer in African-American Women SCHILDKRAUT, JOELLEN UNIVERSITY OF VIRGINIA VA $1,228,381
Ovarian Cancer 2015 NCI 3U54CA096297-13S2 UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297) CRUZ-CORREA, MARCIA UNIVERSITY OF PUERTO RICO MED SCIENCES PR $152,250
Ovarian Cancer 2015 OD 3R01CA138835-06A1S1 The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair GREENBERG, ROGER UNIVERSITY OF PENNSYLVANIA PA $40,000
Ovarian Cancer 2015 NCI 3U54CA096297-13S1 UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2) CRUZ-CORREA, MARCIA UNIVERSITY OF PUERTO RICO MED SCIENCES PR $110,195
Ovarian Cancer 2015 NCI 4R00CA184043-03 Targeting Ovarian Cancer via Cooperative Oncogene Interactions HARGREAVES, DIANA SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $249,000
Ovarian Cancer 2015 NIBIB 7R21EB019147-02 Quantitative Endoscopic Imaging and Structured Light Delivery for Controlled Drug SUNAR, ULAS WRIGHT STATE UNIVERSITY OH $225,227
Ovarian Cancer 2015 NCI 4R00CA166228-03 A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer GATZA, MICHAEL RBHS -CANCER INSTITUTE OF NEW JERSEY NJ $249,000
Ovarian Cancer 2015 NCI 4R00CA184415-02 Functional Analysis of LncRNAs in Epithelial Ovarian Cancer LAWRENSON, KATE CEDARS-SINAI MEDICAL CENTER CA $249,000
Ovarian Cancer 2015 NCI 3P50CA083639-15S1 The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $901,656
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer